K. Matsui

发表

RNAi gene silencing using cerasome as a viral-size siRNA-carrier free from fusion and cross-linking.

Kazuki Matsui, Masaru Mukai, Yoshihiro Sasaki, 2007, Bioorganic & medicinal chemistry letters.

RNAi silencing of exogenous and endogenous reporter genes using a macrocyclic octaamine as a "compact" siRNA carrier. Studies on the nonsilenced residual activity.

K. Matsui, Y. Aoyama, Shohei Horiuchi, 2006, Bioconjugate chemistry.

The provisional no-effect threshold of sugar alcohols on oral drug absorption estimated by physiologically based biopharmaceutics model.

K. Matsui, M. Yamane, Masahisa Sugihara, 2020, Journal of pharmaceutical sciences.

Effects of SM-20550, a New Na+/H+ Exchange Inhibitor, on Survival and Infarct Size in Rat Myocardial Infarction

N. Ohashi, K. Matsui, K. Yamada, 2002, Pharmacology.

In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.

G. Amidon, G. Amidon, K. Matsui, 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Inhibitory effect of SM-20550, an Na+/H+ exchange inhibitor, on accumulation of leukocytes in ischemia and reperfusion

N. Ohashi, K. Matsui, K. Yamada, 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

SM-368229, a novel selective and potent non-steroidal mineralocorticoid receptor antagonist with strong urinary Na+ excretion activity.

K. Fujita, S. Katayama, Tetsuro Nariai, 2011, Journal of pharmacological sciences.

SM-368229, a Novel Promising Mineralocorticoid Receptor Antagonist, Shows Antihypertensive Efficacy With Minimal Effect on Serum Potassium Level in Rats

K. Fujita, S. Katayama, Tetsuro Nariai, 2012, Journal of cardiovascular pharmacology.

Relationship between the neuroprotective effect of Na+/H+ exchanger inhibitor SM-20220 and the timing of its administration in a transient middle cerebral artery occlusion model of rats.

N. Ohashi, K. Matsui, N. Horikawa, 2001, Biological & pharmaceutical bulletin.

A Na+-H+ exchange inhibitor (SM-20550) protects from microvascular deterioration and myocardial injury after reperfusion.

R. Nagai, S. Imai, N. Ohashi, 1999, European journal of pharmacology.

Bioequivalence of Oral Drug Products in the Healthy and Special Populations: Assessment and Prediction Using a Newly Developed In Vitro System “BE Checker”

M. Kataoka, S. Yamashita, K. Matsui, 2021, Pharmaceutics.

Effects of Bepridil and Pimozide, Existing Medicines Capable of Blocking T-Type Ca2+ Channels, on Visceral Pain in Mice.

K. Matsui, A. Kawabata, F. Sekiguchi, 2021, Biological & pharmaceutical bulletin.

Facile preparation of DNA-tagged carbohydrates.

K. Matsui, Y. Aoyama, S. Sando, 2003, Bioorganic & medicinal chemistry letters.

Comparative studies of thrombolysis with single-chain and two-chain recombinant tissue-type plasminogen activators in canine coronary thrombosis.

K. Matsui, O. Matsuo, S. Ueshima, 1996, Journal of cardiovascular pharmacology.

A novel class of sodium/calcium exchanger inhibitor: design, synthesis, and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives.

K. Matsui, H. Hasegawa, M. Muraoka, 2005, Bioorganic & medicinal chemistry.

Antihypertensive and Cardiorenal Protective Effects of SM-368229, a Novel Mineralocorticoid Receptor Antagonist, in Aldosterone/Salt-Treated Rats

K. Fujita, S. Katayama, Tetsuro Nariai, 2012, Pharmacology.

Cerasome as an infusible, cell-friendly, and serum-compatible transfection agent in a viral size.

Y. Sasaki, K. Matsui, Takayoshi Komatsu, 2006, Journal of the American Chemical Society.

Reduction of myocardial infarct size by SM-198110, a novel Na+/H+ exchange inhibitor, in rabbits

N. Ohashi, K. Matsui, K. Yamada, 2005, Naunyn-Schmiedeberg's Archives of Pharmacology.

Reduction of myocardial infarct size by SM-20550, a novel Na(+)/H(+) exchange inhibitor, in rabbits.

S. Yamamoto, N. Ohashi, K. Matsui, 2000, European journal of pharmacology.

Na+/H+ Exchange Inhibitor SM‐20220 Attenuates Leukocyte Adhesion Induced By Ischemia‐Reperfusion

N. Ohashi, K. Matsui, N. Horikawa, 2001, Journal of cardiovascular pharmacology.

The Na+/H+ Exchanger SM-20220 Attenuates Ischemic Injury in in vitro and in vivo Models

N. Ohashi, K. Matsui, N. Horikawa, 2001, Pharmacology.

Differences in the effects of Na+-H+ exchange inhibitors on cardiac function and apoptosis in guinea-pig ischemia-reperfused hearts.

N. Ishikawa, N. Ohashi, K. Matsui, 2004, European journal of pharmacology.

Effects of SM-20550, a selective Na+-H+ exchange inhibitor, on the ion transport of myocardial mitochondria

N. Ishikawa, N. Ohashi, K. Matsui, 2001, Molecular and Cellular Biochemistry.

Protective Effect of Na+/H+ Exchange Inhibitor, SM-20550, on Impaired Mitochondrial Respiratory Function and Mitochondrial Ca2+ Overload in Ischemic/Reperfused Rat Hearts

N. Ohashi, K. Matsui, Setsuko Yamamoto, 2002, Journal of cardiovascular pharmacology.

Effect of an Orally Active Na + /H + Exchange Inhibitor, SMP-300, on Experimental Angina and Myocardial Infarction Models in Rats

N. Ohashi, K. Matsui, M. Sasabe, 2002, Journal of cardiovascular pharmacology.

Protective Effect of SM-20550, a Selective Na+-H+ Exchange Inhibitor, on Ischemia-Reperfusion-Injured Hearts

N. Ishikawa, N. Ohashi, K. Matsui, 2001, Journal of cardiovascular pharmacology.

Effect of SMP-300, a new Na+/H+ exchange inhibitor, on myocardial ischemia and experimental angina models in rats.

S. Yamamoto, N. Ohashi, K. Matsui, 2000, Japanese journal of pharmacology.

SM-20550, a new Na+/H+ exchange inhibitor and its cardioprotective effect in ischemic/reperfused isolated rat hearts by preventing Ca2+-overload.

S. Yamamoto, N. Ohashi, K. Matsui, 2000, Journal of cardiovascular pharmacology.

Na+/H+ exchange inhibitor SM-20220 improves endothelial dysfunction induced by ischemia-reperfusion.

N. Ohashi, K. Matsui, N. Horikawa, 2001, Japanese journal of pharmacology.

Anti‐arrhythmic effects of (‐)‐carnitine chloride and its acetyl analogue on canine late ventricular arrhythmia induced by ligation of the coronary artery as related to improvement of mitochondrial function

M. Nakazawa, K. Matsui, S. Imai, 1984, British journal of pharmacology.

A novel class of sodium/calcium exchanger inhibitors: design, synthesis, and structure-activity relationships of 4-phenyl-3-(piperidin-4-yl)-3,4-dihydro-2(1H)-quinazolinone derivatives.

K. Matsui, H. Hasegawa, M. Muraoka, 2006, Bioorganic & medicinal chemistry letters.

Discovery of a novel potent Na+/Ca2+ exchanger inhibitor: design, synthesis and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives.

K. Matsui, H. Hasegawa, M. Muraoka, 2003, Bioorganic & medicinal chemistry letters.

The Evaluation of In Vitro Drug Dissolution of Commercially Available Oral Dosage Forms for Itraconazole in Gastrointestinal Simulator With Biorelevant Media.

G. Amidon, G. Amidon, K. Matsui, 2016, Journal of pharmaceutical sciences.

The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS)

Kazuki Matsui, Yasuhiro Tsume, Gordon L Amidon, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): An in vitro‐in silico‐in vivo approach

Marival Bermejo, Bart Hens, Gregory E. Amidon, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Essential role of Cav3.2 T-type calcium channels in butyrate-induced colonic pain and nociceptor hypersensitivity in mice.

K. Matsui, A. Kawabata, F. Sekiguchi, 2020, European journal of pharmacology.

Genetic deletion of Cav3.2 T-type calcium channels abolishes H2S-dependent somatic and visceral pain signaling in C57BL/6 mice.

K. Matsui, H. Masuda, Takaya Miyazaki, 2019, Journal of pharmacological sciences.

Transverse comparison of mannitol content in marketed drug products: Implication for no-effect dose of sugar alcohols on oral drug absorption

Takahiro Shimizu, K. Matsui, M. Yamane, 2020, Journal of Drug Delivery Science and Technology.

Enhanced responsiveness of the coronary blood vessel of the dog heart-lung preparation to PGI2 after chronic chemical sympathectomy.

M. Nakazawa, K. Matsui, S. Imai, 1985, Japanese journal of pharmacology.

In Vitro Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting in Vivo Dissolution and Drug-Drug Interaction Caused by Acid-Reducing Agents.

Kazuki Matsui, Yasuhiro Tsume, G. Amidon, 2015, Molecular pharmaceutics.

Utilization of Gastrointestinal Simulator, an in Vivo Predictive Dissolution Methodology, Coupled with Computational Approach To Forecast Oral Absorption of Dipyridamole.

G. Amidon, K. Matsui, Y. Tsume, 2017, Molecular pharmaceutics.

Design, synthesis, and structure-activity relationships of 3,4-dihydropyridopyrimidin-2(1H)-one derivatives as a novel class of sodium/calcium exchanger inhibitor.

K. Matsui, H. Hasegawa, M. Muraoka, 2005, Chemical & pharmaceutical bulletin.

Cardiotonic and coronary vasodilatatory effects of amrinone in the canine heart-lung preparation with a support dog as compared with those of dobutamine.

M. Nakazawa, K. Matsui, S. Imai, 1986, Japanese journal of pharmacology.

Tacrolimus, a calcineurin inhibitor, promotes capsaicin-induced colonic pain in mice.

K. Matsui, A. Kawabata, F. Sekiguchi, 2020, Journal of pharmacological sciences.

In Vivo and In Vitro Assessment of the Cardiovascular Effects of 8-(Benzylthio)-N6-n-Butyl–Cyclic AMP

T. Kawada, M. Nakazawa, K. Matsui, 1985, Journal of cardiovascular pharmacology.

Lowly-buffered biorelevant dissolution testing is not necessarily biopredictive of human bioequivalence study outcome: Relationship between dissolution and pharmacokinetics.

S. Yamashita, K. Matsui, S. Yokota, 2022, International journal of pharmaceutics.

Relationship between serum bepridil concentration and corrected QT interval.

K. Matsui, Tsutomu Nakamura, K. Kusano, 2020, International journal of clinical pharmacology and therapeutics.

Cerasome as an infusible and cell-friendly gene carrier: synthesis of cerasome-forming lipids and transfection using cerasome

Y. Sasaki, K. Matsui, J. Kikuchi, 2006, Nature Protocols.

In Vitro Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting in Vivo Dissolution and Drug-Drug Interaction Caused by Acid-Reducing Agents.

G. Amidon, G. Amidon, K. Matsui, 2015, Molecular pharmaceutics.

SM-368229, a Novel Promising Mineralocorticoid Receptor Antagonist, Shows Antihypertensive Efficacy With Minimal Effect on Serum Potassium Level in Rats

K. Fujita, S. Katayama, Tetsuro Nariai, 2012, Journal of cardiovascular pharmacology.